Additionally, mIHC staining revealed an increase in M2-type TAMs positive for CD163 and CD68 within the tumor regions, whereas CD206 was poorly expressed, indicating that CD163 was a better marker in this scenario (Fig. 6d). This evidence concerns the gene MRC1 and neoplasm.